Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.
Saved in:
| Title: | Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs. |
|---|---|
| Authors: | Koopman LA; Genmab (Netherlands) Utrecht Netherlands., Alemdehy F; Genmab (Netherlands) Utrecht Netherlands., de Poot SAH; Genmab (Netherlands) Utrecht Netherlands., Paauwe M; Genmab (Netherlands) Utrecht Netherlands., Wang W; Genmab (Netherlands) Utrecht Netherlands., Epstein KR; University of Pennsylvania Philadelphia United States., van den Brink EN; Genmab (Netherlands) Utrecht Netherlands., Gorlani A; Genmab (Netherlands) Utrecht Netherlands., Verzijl D; Genmab (Netherlands) Utrecht Netherlands., Brandhorst M; Genmab (Netherlands) Utrecht Netherlands., Franken P; Genmab (Netherlands) Utrecht Netherlands., Smits-de Vries L; Genmab (Netherlands) Utrecht Netherlands., Gielen E; Genmab (Netherlands) Utrecht Netherlands., Plantinga TS; Genmab (Netherlands) Utrecht Netherlands., Houtkamp M; Genmab (Netherlands) Utrecht Netherlands., Engelberts PJ; Genmab (Netherlands) Utrecht Netherlands., Lihme Egerod F; Genmab (Denmark) Copenhagen Denmark., Thalhauser CJ; Genmab (United States) Plainsboro, New Jersey United States., Bosgra S; Genmab (Netherlands) Utrecht Netherlands., Gitto SB; University of Pennsylvania Philadelphia, PA United States., Powell DJ; University of Pennsylvania Philadelphia, PA United States., Gamse JT; Genmab (United States) Plainsboro, NJ United States., Overdijk MB; Genmab (Netherlands) Utrecht, utrecht Netherlands., Breij ECW; Genmab (Netherlands) Utrecht Netherlands. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 30. Date of Electronic Publication: 2026 Jun 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42374845 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koopman+LA%22">Koopman LA</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Alemdehy+F%22">Alemdehy F</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Poot+SAH%22">de Poot SAH</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Paauwe+M%22">Paauwe M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Epstein+KR%22">Epstein KR</searchLink>; University of Pennsylvania Philadelphia United States.<br /><searchLink fieldCode="AU" term="%22van+den+Brink+EN%22">van den Brink EN</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gorlani+A%22">Gorlani A</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Verzijl+D%22">Verzijl D</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Brandhorst+M%22">Brandhorst M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Franken+P%22">Franken P</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Smits-de+Vries+L%22">Smits-de Vries L</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gielen+E%22">Gielen E</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Plantinga+TS%22">Plantinga TS</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Houtkamp+M%22">Houtkamp M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Engelberts+PJ%22">Engelberts PJ</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Lihme+Egerod+F%22">Lihme Egerod F</searchLink>; Genmab (Denmark) Copenhagen Denmark.<br /><searchLink fieldCode="AU" term="%22Thalhauser+CJ%22">Thalhauser CJ</searchLink>; Genmab (United States) Plainsboro, New Jersey United States.<br /><searchLink fieldCode="AU" term="%22Bosgra+S%22">Bosgra S</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gitto+SB%22">Gitto SB</searchLink>; University of Pennsylvania Philadelphia, PA United States.<br /><searchLink fieldCode="AU" term="%22Powell+DJ%22">Powell DJ</searchLink>; University of Pennsylvania Philadelphia, PA United States.<br /><searchLink fieldCode="AU" term="%22Gamse+JT%22">Gamse JT</searchLink>; Genmab (United States) Plainsboro, NJ United States.<br /><searchLink fieldCode="AU" term="%22Overdijk+MB%22">Overdijk MB</searchLink>; Genmab (Netherlands) Utrecht, utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Breij+ECW%22">Breij ECW</searchLink>; Genmab (Netherlands) Utrecht Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Jun 30. <i>Date of Electronic Publication: </i>2026 Jun 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42374845 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-26-0054 Languages: – Code: eng Text: English Titles: – TitleFull: Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koopman LA – PersonEntity: Name: NameFull: Alemdehy F – PersonEntity: Name: NameFull: de Poot SAH – PersonEntity: Name: NameFull: Paauwe M – PersonEntity: Name: NameFull: Wang W – PersonEntity: Name: NameFull: Epstein KR – PersonEntity: Name: NameFull: van den Brink EN – PersonEntity: Name: NameFull: Gorlani A – PersonEntity: Name: NameFull: Verzijl D – PersonEntity: Name: NameFull: Brandhorst M – PersonEntity: Name: NameFull: Franken P – PersonEntity: Name: NameFull: Smits-de Vries L – PersonEntity: Name: NameFull: Gielen E – PersonEntity: Name: NameFull: Plantinga TS – PersonEntity: Name: NameFull: Houtkamp M – PersonEntity: Name: NameFull: Engelberts PJ – PersonEntity: Name: NameFull: Lihme Egerod F – PersonEntity: Name: NameFull: Thalhauser CJ – PersonEntity: Name: NameFull: Bosgra S – PersonEntity: Name: NameFull: Gitto SB – PersonEntity: Name: NameFull: Powell DJ – PersonEntity: Name: NameFull: Gamse JT – PersonEntity: Name: NameFull: Overdijk MB – PersonEntity: Name: NameFull: Breij ECW IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 06 Text: 2026 Jun 30 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1538-8514 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |